Risk-Factor Based Lead Screening and Correlation with Blood Lead Levels in Pregnancy.
Risk-Factor Based Lead Screening and Correlation with Blood Lead Levels in Pregnancy.
复制标题
DOI:
10.1007/s10995-021-03325-x
复制
发表时间:
2022-01
影响因子:
2.3
通讯作者:
Wylie BJ
中科院分区:
文献类型:
--
作者:
Johnson KM;Specht AJ;Hart JM;Salahuddin S;Erlinger AL;Hacker MR;Woolf AD;Hauptman M;Karumanchi SA;O'Brien K;Wylie BJ
Lead exposure has devastating neurologic consequences for children and may begin in utero. The American College of Obstetricians and Gynecologists recommends prenatal lead screening using a risk factor-based approach rather than universal blood testing. The clinical utility of this approach has not been studied. We evaluated a risk-factor based questionnaire to detect elevated blood lead levels in pregnancy. We performed a secondary analysis of a cohort of parturients enrolled to evaluate the association of lead with hypertensive disorders of pregnancy. We included participants in this analysis if they had a singleton pregnancy ≥34 weeks’ gestation with blood lead levels recorded. Participants completed a lead risk factor survey modified for pregnancy. We defined elevated blood lead as ≥2 μg/dL, as this was the clinically reportable level. Of 102 participants enrolled in the cohort, 92 had blood lead measured as part of the study. The vast majority (78%) had 1 or more risk factor for elevated lead using the questionnaire yet none had clinical blood lead testing during routine visits. Only two participants (2.2%) had elevated blood lead levels. The questionnaire had high sensitivity but poor specificity for predicting detectable lead levels (sensitivity 100%, specificity 22%). Prenatal risk-factor based lead screening appears underutilized in practice and does not adequately discriminate between those with and without elevated blood levels. Given the complexity of the risk factor-based approach and underutilization, the benefit and cost-effectiveness of universal lead testing should be further explored.
登录
查看更多内容
影响因子:
3.7
作者:
Liu J;Li L;Wang Y;Yan C;Liu X
通讯作者:
Liu X
影响因子:
2.3
作者:
Bakhireva LN;Rowland AS;Young BN;Cano S;Phelan ST;Artyushkova K;Rayburn WF;Lewis J
通讯作者:
Lewis J
DOI:
10.1093/jurban/79.2.225
发表时间:
2002-06-01
影响因子:
6.6
作者:
Klitzman, S;Sharma, A;Leighton, J
通讯作者:
Leighton, J
DOI:
10.1016/j.preghy.2020.07.014
发表时间:
2020-10
期刊:
Pregnancy hypertension
影响因子:
--
作者:
Johnson KM;Specht AJ;Hart JM;Salahuddin S;Erlinger AL;Hacker MR;Woolf AD;Hauptman M;Karumanchi SA;Wylie BJ;O'Brien K
通讯作者:
O'Brien K
影响因子:
10.4
作者:
Jusko, Todd A.;Henderson, ChaKes R., Jr.;Lanphear, Bruce P.;Cory-Slechta, Deborah A.;Parsons, Patrick J.;Canfield, Richard L.
通讯作者:
Canfield, Richard L.